Charles T. Nomides
Nessuna posizione attualmente
Profilo
Charles T.
Nomides was appointed Chief Research and Development Officer for Barrier Therapeutics, Inc. in February 2006.
From July 2002 to February 2006, he served as Chief Operating Officer of Barrier Therapeutics.
From 1997 to 2002, he was employed by Johnson & Johnson Consumer Products Worldwide, where he served as Director of Research and Development in charge of the Ortho Neutrogena Prescription Drug Development Group.
Mr. Nomides received a Bachelor's degree in Biology from Clarion State University and graduate training from Temple University and The Milton S.
Hershey Medical Center.
Precedenti posizioni note di Charles T. Nomides
| Società | Posizione | Fine |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Direttore Tecnico/Scientifico/R&S | 13/09/2007 |
Johnson & Johnson Consumer Products Co.
 Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Direttore Tecnico/Scientifico/R&S | 01/01/2002 |
Formazione di Charles T. Nomides
| Clarion University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Johnson & Johnson Consumer Products Co.
Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Consumer Non-Durables |
- Borsa valori
- Insiders
- Charles T. Nomides
